Panion BF Financials
| 1760 Stock | TWD 89.00 1.90 2.09% |
Panion |
Understanding current and past Panion BF Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Panion BF's financial statements are interrelated, with each one affecting the others. For example, an increase in Panion BF's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Panion BF's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Panion BF Biotech. Check Panion BF's Beneish M Score to see the likelihood of Panion BF's management manipulating its earnings.
Panion BF Stock Summary
Panion BF competes with Symtek Automation, WiseChip Semiconductor, Novatek Microelectronics, Leader Electronics, and Information Technology. Panion Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. Panion Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei City, Taiwan. PANION BF operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.| Foreign Associate | Taiwan |
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0001760007 |
| Business Address | Building F, Taipei, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.pbf.com.tw |
| Phone | 886 2 2655 8218 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Panion BF without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Panion Stock, because this is throwing your money away. Analyzing the key information contained in Panion BF's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Panion BF Key Financial Ratios
There are many critical financial ratios that Panion BF's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Panion BF Biotech reports annually and quarterly.| Return On Equity | 0.14 | |||
| Return On Asset | 0.0805 | |||
| Target Price | 106.0 | |||
| Number Of Employees | 16 | |||
| Beta | 0.52 |
Panion Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Panion BF's current stock value. Our valuation model uses many indicators to compare Panion BF value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Panion BF competition to find correlations between indicators driving Panion BF's intrinsic value. More Info.Panion BF Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Panion BF Biotech is roughly 1.68 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Panion BF's earnings, one of the primary drivers of an investment's value.Panion BF Biotech Systematic Risk
Panion BF's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Panion BF volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on Panion BF Biotech correlated with the market. If Beta is less than 0 Panion BF generally moves in the opposite direction as compared to the market. If Panion BF Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Panion BF Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Panion BF is generally in the same direction as the market. If Beta > 1 Panion BF moves generally in the same direction as, but more than the movement of the benchmark.
Panion BF December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Panion BF help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Panion BF Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Panion BF Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Panion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Panion BF's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 6.62 | |||
| Value At Risk | (2.09) | |||
| Potential Upside | 2.25 |
Additional Tools for Panion Stock Analysis
When running Panion BF's price analysis, check to measure Panion BF's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panion BF is operating at the current time. Most of Panion BF's value examination focuses on studying past and present price action to predict the probability of Panion BF's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panion BF's price. Additionally, you may evaluate how the addition of Panion BF to your portfolios can decrease your overall portfolio volatility.